BridgeBio Pharma Inc.
BridgeBio Pharma Inc. (BBIO) — Form SCHEDULE 13G/A: Ownership over 5% (passive) (amendment)
About this filing
BridgeBio Pharma Inc. (BBIO) filed Form SCHEDULE 13G/A (ownership over 5% (passive) (amendment)) with the SEC on Nov 12, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.
Key facts
- Document
- —
More BBIO filings
- 4
Filed Nov 3, 2026
- 10-Q
Filed Oct 29, 2026
- 8-K
Filed Oct 29, 2026
- SC 13G
Filed Oct 27, 2026
- 8-K
Filed Oct 13, 2026
- 4
Filed Sep 21, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.